High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study
Abstract
Background— Advanced glycation end products (AGEs), modification products of glycation or glycoxidation of proteins and lipids, have been linked to premature atherosclerosis in patients with diabetes as well as in nondiabetic subjects. Methods and Results— Serum levels of AGEs were measured with an immunoassay in samples obtained at baseline examination of a random sample of 1141 nondiabetic individuals (535 men and 606 women), aged 45 to 64 years, living in Kuopio, East Finland, or Turku, West Finland in 1982 to 1984. After 18 years of follow-up, all-cause mortality, cardiovascular disease (CVD), and coronary heart disease (CHD) mortality were registered on the basis of copies of death certificates. Multivariate Cox regression model showed a significant association of serum AGEs with all-cause ( P =0.012), CVD ( P =0.018), and CHD ( P =0.008) mortality in women but not in men. Fasting serum AGEs in the highest quartile were an independent risk factor for all-cause (hazards ratio [HR], 1.90; 95% CI, 1.16 to 3.11; P =0.011) and CHD (HR, 6.51; 95% CI, 1.78 to 23.79; P =0.005) mortality in women, even after the adjustment for confounding factors, including highly sensitive C-reactive protein. Conclusions— The present study is the first to show that serum levels of AGEs can predict total, CVD, and CHD mortality in nondiabetic women.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AGE can predict total, cardiovascular disease and coronary heart disease mortality in nondiabetic women.
“Laakso’s group (177) conducted a comprehensive 18-yr follow-up study in Finnish subjects which was the first to demonstrate that AGE can predict total, cardiovascular disease and coronary heart disease mortality in nondiabetic women.”
From Cardiac remodeling in obesity (2008) · cites this paper as [177]
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107 · see citing works
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312 · see citing works
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,162 · see citing works
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103 · see citing works
Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118175 · Cited by 896 · see citing works
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Yan, S. D., Hofmann, M. A., Yan, S. F., Pischetsrieder, M., Stern, D. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 868 · see citing works
Schmidt, A. M., Vianna, M., Gerlach, M. L., Brett, J., Ryan, J., Kao, J. J., Esposito, C., Hegarty, H. M., Hurley, W. L., & Clauss, M. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42137-0 · Cited by 833 · see citing works
Fu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822 · see citing works
Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R., Scuteri, A., deGroof, R. C., & Lakatta, E. G. (2001) · Circulation · doi:10.1161/hc3801.097806 · Cited by 727 · see citing works
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668 · see citing works
Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., & Vlassara, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6434 · Cited by 571 · see citing works
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 562 · see citing works
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I. D., Mitsuhashi, T., Giordano, D., VanPatten, S., Lee, A., Al‐Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 550 · see citing works
Reddy, S., Bichler, J., Wells‐Knecht, K. J., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00034a021 · Cited by 524 · see citing works
Glycoxidation and lipoxidation in atherogenesis
Baynes, J., & Thorpe, S. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00228-8 · Cited by 515 · see citing works
Immunochemical detection of advanced glycosylation end products in vivo.
Makita, Z., Vlassara, H., Cerami, A., & Bucala, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42741-x · Cited by 491 · see citing works
Bucala, R., Makita, Z., Vega, G., Grundy, S. M., Koschinsky, T., Cerami, A., & Vlassara, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9441 · Cited by 471 · see citing works
Breakers of advanced glycation end products restore large artery properties in experimental diabetes
Wolffenbuttel, B. H. R., Boulanger, C. M., Crijns, F. R. L., Huijberts, M. S., Poitevin, P., Swennen, G., Vasan, S., Egan, J. J., Ulrich, P. C., Cerami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4630 · Cited by 434 · see citing works
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421 · see citing works
Li, Y. M., Mitsuhashi, T., Wojciechowicz, D. C., Shimizu, N., Li, J., Stitt, A. W., He, C., Banerjee, D., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11047 · Cited by 340 · see citing works
Kume, S., Takeya, M., Mori, T., Araki, N., Suzuki, H., Horiuchi, S., Kodama, T., Miyauchi, Y., & Takahashi, K. (1995) · Europe PMC (PubMed Central) · Cited by 295 · see citing works
Kostner, G. M. (1976) · Clinical Chemistry · doi:10.1093/clinchem/22.5.0695a · Cited by 279 · see citing works
The role of glycation cross-links in diabetic vascular stiffening
Sims, T. J., Rasmussen, L. M., Oxlund, H., & Bailey, A. J. (1996) · Diabetologia · doi:10.1007/bf00403914 · Cited by 259 · see citing works
Vlassara, H., Fuh, H., Donnelly, T. M., & Cybulsky, M. I. (1995) · Molecular Medicine · doi:10.1007/bf03401582 · Cited by 243 · see citing works
Lipoprotein glycation and its metabolic consequences
Lyons, T. J., & Jenkins, A. J. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00008 · Cited by 232 · see citing works
Glycation and oxidation: A role in the pathogenesis of atherosclerosis
Lyons, T. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90142-y · Cited by 221 · see citing works
AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression
Boulanger, É., Wautier, M., Wautier, J., Boval, B., Panis, Y. H., Wernert, N., Danzé, P. M., & Dequiedt, P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00115.x · Cited by 162 · see citing works
Laakso, M., Rönnemaa, T., Pyörälà, K., Kallio, V., Puukka, P. J., & Penttilä, I. (1988) · Diabetes Care · doi:10.2337/diacare.11.6.449 · Cited by 153 · see citing works
Self-citationNicholl, I. D., Stitt, A. W., Moore, J. E., Ritchie, A. J., ARCHER, D. B., & Bucala, R. (1998) · Molecular Medicine · doi:10.1007/bf03401759 · Cited by 152 · see citing works
Berg, T. J., Bangstad, H. ‐., Torjesen, P. A., Østerby, R., Bucala, R., & Hanssen, K. F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90010-x · Cited by 125 · see citing works
Self-citationAdvanced Glycation End Products in Nondiabetic Patients With Coronary Artery Disease
Kanauchi, M., Tsujimoto, N., & Hashimoto, T. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1620 · Cited by 112 · see citing works
Kostner, G. M. (1976) · Clinical Chemistry · doi:10.1093/clinchem/22.5.695a · Cited by 104 · see citing works
Berg, T. J., Clausen, J. T., Torjesen, P. A., Dahl‐Jørgensen, K., Bangstad, H. ‐., & Hanssen, K. F. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1997 · Cited by 90 · see citing works
Self-citationLetter: Effects of medication of plasma vitamin A concentrations.
Curtis, J. L., & Swicord, W. (1976) · Clinical Chemistry · doi:10.1093/clinchem/22.5.695 · Cited by 34 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Advanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751 · see citing works
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736 · see citing works
Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G., & Vlassara, H. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.4.427 · Cited by 570 · see citing works
Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes
Uribarri, J., Cai, W., Ramdas, M., Goodman, S., Pyzik, R., Chen, X., Zhu, L., Striker, G. E., & Vlassara, H. (2011) · Diabetes Care · doi:10.2337/dc11-0091 · Cited by 320 · see citing works
Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study
Brunner, E. J., Shipley, M. J., Witte, D. R., Fuller, J. H., & Marmot, M. G. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1405 · Cited by 166 · see citing works
Koska, J., Saremi, A., Howell, S., Bahn, G., De Courten, B., Ginsberg, H., Beisswenger, P. J., Reaven, P. D., & for the VADT Investigators (2018) · Diabetes Care · doi:10.2337/dc17-1740 · Cited by 134 · see citing works
Tahara, N., Yamagishi, S., Matsui, T., Takeuchi, M., Nitta, Y., Kodama, N., Mizoguchi, M., & Imaizumi, T. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00177.x · Cited by 116 · see citing works
- Authors
- Kilhovd, B. K., Juutilainen, A., Lehto, S., Rönnemaa, T., Torjesen, P. A., Birkeland, K. I., Berg, T. J., Hanssen, K. F., & Laakso, M.
- Affiliations
- Oslo University Hospital (NO)
- From the Diabetes Research Centre, Aker and Ullevål University Hospitals and Department of Medicine (B.K.K., T.J.B., K.F.H.) and the Hormone Laboratory (P.A.T., K.I.B.), Aker University Hospital HF, Oslo; the Department of Medicine (A.J., S.L., M.L.), University of Kuopio and Kuopio University Hospital; and the Department of Medicine (T.R.), University of Turku, Finland.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2005-04
- Volume
- 25
- Issue
- 4
- Pages
- 815-820
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2100032971
- Cited by
- 122
- References
- 35
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 1 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 9 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 3 · 2014: 7 · 2013: 9 · 2012: 10
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- advanced glycation end products, coronary heart disease mortality, cardiovascular mortality, all-cause mortality, sex differences, non-diabetic women, non-diabetic men, serum biomarkers, C-reactive protein, premature atherosclerosis
- MeSH terms
- Coronary Disease, Diabetes Mellitus, Female, Finland, Follow-Up Studies, Humans, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Biomarkers, Proportional Hazards Models, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
